These studies not only provide new insights into the BRD4-mediated cancer cell proliferation but also provide potential new targets for the treatment of gastric cancer by targeting the E2F/miRNA-106b-5p/p21 axis. This evidence concerns the gene CDKN1A and gastric cancer.